Week 3: Latest Advances in Brain Research: 

Brain science has entered a remarkable new era. In recent years, rigorous studies have moved brain health from a theoretical concept to actionable strategies. Randomized trials now show that lifestyle changes can improve cognition, new blood tests can clarify the type of memory problem a person has, and disease-modifying drugs for early Alzheimer’s disease have received FDA approval. Large reviews continue to refine the list of modifiable risk factors, highlighting the most effective interventions for protecting the aging brain. For older adults, this evidence is both hopeful and practical. Maintaining brain fitness is not about miracle cures but about combining small, daily habits that support cognition and quality of life. 

Key Lesson: You are not powerless against age-related cognitive decline. Everyday choices regarding diet, movement, sleep, social connection, and routine health care measurably impact brain function. 

Cognition refers to the brain’s abilities: memory, attention, reasoning, language, and problem-solving. 

• Mild Cognitive Impairment (MCI): When thinking skills decline more than expected for age but do not yet interfere with independence. 
   

• Dementia: Severe cognitive decline that interferes with daily living, with Alzheimer’s disease being the most common cause. 
   

• Biomarkers: Biological measures such as proteins in blood or spinal fluid that help identify diseases like Alzheimer’s before symptoms are severe. 
   

Upside: By identifying risk factors early and adopting protective habits, many people can delay or reduce decline. 

Multidomain Lifestyle Programs  

The U.S. POINTER study (2025) demonstrated that a combination of physical activity, healthy diet, social and cognitive engagement, and management of blood pressure and diabetes helps maintain cognitive abilities in older adults at risk for decline. Programs delivered with accountability and coaching support produced measurable improvements in memory and other cognitive domains. These results mirror the earlier Finnish FINGER study, confirming that lifestyle interventions are effective in the U.S. population. 

Upside: A comprehensive lifestyle approach provides synergistic benefits that outperform isolated interventions. 

High blood pressure damages small blood vessels in the brain, silently increasing dementia risk. The SPRINT-MIND study found that intensive treatment of systolic blood pressure to below 120 mmHg reduced the risk of MCI and showed a favorable trend for dementia prevention. 

Upside: Partnering with your clinician to manage blood pressure is one of the most impactful, evidence-based steps for protecting cognition. 

Sleep is critical for brain clearance. During deep slow-wave sleep, the glymphatic system removes metabolic waste such as amyloid proteins. Poor sleep or sleep apnea may elevate dementia risk over years. 

Practical tips: 

• Keep a regular bedtime schedule.  

• Limit caffeine after noon.  

• Limit screen time before bed.  

• Seek evaluation for sleep apnea if snoring, gasping, or unrefreshing sleep occurs.
  
  

Upside: Consistent, high-quality sleep improves energy, mood, and may reduce long-term risk for Alzheimer’s disease. 

Exercise strengthens the brain through multiple mechanisms: increased blood flow, stimulation of neurotrophic factors, and structural support for memory. Aerobic activity supports processing speed, resistance training improves executive function, and balance work reduces falls while engaging cognitive networks. 

Recommendations: 

• 150 minutes per week of moderate aerobic activity (30 min/day × 5 days).   

• Strength training twice weekly.   

• Add balance-focused exercises like tai chi or yoga.  
   

Upside: Regular movement enhances cognition, sleep quality, mood, and independence. 

Social connection is protective of cognition. The 2024 Lancet Commission highlighted social isolation and sensory deficits as modifiable dementia risk factors. 

Practical examples: 

• Join a class, book club, or volunteer group.  

• Combine social interaction with physical activity, such as walking with friends.
   

Upside: Engaged social life stimulates multiple brain regions and improves emotional well-being. 

Neuroplasticity in Older Adults 

Neuroplasticity, the brain's ability to change, continues well into old age. Learning new skills, such as a language or musical instrument, increases connectivity in cognitive networks and strengthens cognitive reserve. 

Upside: Lifelong learning acts as a mental buffer against decline. 

The hippocampus retains neurogenesis capabilities throughout adulthood. Physical activity, diet, and mental exercises boost memory formation. Associative memory training, linking faces and names or words and images, strengthens neural networks. Emerging brain stimulation techniques, including tDCS and TMS, show promise in enhancing memory and neuroplasticity. 

Upside: Memory is adaptable, and targeted interventions can strengthen recall and cognitive skills. 

Brain shrinkage occurs in the hippocampus and prefrontal cortex with age (Raz et al., 2021). Cognitive reserve—the ability to use alternative networks to maintain function—is influenced by education, complex work, and stimulating hobbies (Stern, 2019; Fratiglioni et al., 2018). 

Upside: Mental challenge, creative pursuits, and engaging activities help delay cognitive decline.

Amyloid and Tau PET Imaging 

Amyloid and tau PET imaging are novel biomarkers that can detect Alzheimer’s pathology years before clinical symptoms emerge. These imaging techniques visualize the accumulation of amyloid plaques and tau tangles in the brain, providing a clear biological signature of disease progression. 

Upside: Early detection allows timely interventions and reduces diagnostic uncertainty. 

Lecanemab and donanemab, FDA-approved for early symptomatic Alzheimer’s disease, modestly slow cognitive decline in patients with confirmed amyloid plaques. Careful MRI monitoring is required for amyloid-related imaging abnormalities. Aducanumab was the first FDA-approved anti-amyloid drug but was later discontinued due to severe complications. Several other drugs targeting amyloid and tau are in development. 

Upside: These drugs are the first to target underlying Alzheimer’s biology, complementing lifestyle interventions. 

Digital biomarkers, including smartphones and wearable data, can predict cognitive decline before traditional clinical signs appear. For example, AI algorithms analyzing speech patterns during cognitive tests predicted progression from mild cognitive impairment to Alzheimer’s disease with over 78% accuracy within six years. These technologies can complement traditional biomarkers like PET imaging and blood assays. 

Upside: Early, noninvasive detection enables proactive lifestyle and medical interventions, potentially delaying disease progression. 

Lithium, long used as a psychiatric medication, is being studied at low doses (subtherapeutic for mood disorders) for neuroprotection. Research suggests it may reduce tau phosphorylation, neuroinflammation, and oxidative stress—mechanisms implicated in Alzheimer’s disease. Low-dose regimens may avoid the side effects associated with standard therapeutic levels. 

Upside: Lithium offers a promising, low-cost approach for slowing Alzheimer’s-related neurodegeneration, complementing lifestyle and pharmacological strategies. 

The image shows lithium’s history as a psychiatric treatment and its wide-ranging biological benefits on the brain, explaining why it’s still so important for treating mood disorders and being researched in neurodegeneration. 

The World Economic Forum (2025) highlighted eight recent advances: 

1. Early detection via blood-based and imaging biomarkers.  

2. AI and machine learning for predictive diagnostics.  

3. Gene therapy and editing approaches.   

4. Disease-modifying antibodies targeting amyloid and tau.  

5. Low-dose lithium and other repurposed drugs.   

6. Noninvasive brain stimulation techniques.  

7. Digital twin modeling for individualized intervention planning.  

8. Integration of precision medicine approaches clinical trials. 
    

Upside: The convergence of pharmacology, technology, and personalized medicine offers multiple pathways to slow or prevent cognitive decline.  

Technology can actively support cognition when used intentionally. 

As technology becomes increasingly integrated into daily life, researchers are examining how digital tools influence cognitive health. Far from being purely distracting, carefully designed technology can provide structured support for memory, attention, and engagement. Evidence suggests that older adults who adopt select digital interventions may experience improvements in independence and well-being.  

Cognitive Training Software: Digital training platforms, often delivered through computer programs or mobile applications, have shown measurable benefits for attention and working memory. A meta-analysis of more than 50 trials found that structured digital training improved executive function, processing speed, and visuospatial skills in older adults. However, generalization to everyday functioning is most robust when training mimics real-world tasks rather than abstract puzzles. Programs that adapt difficulty to the user’s performance also appear more effective. 

Wearable Technology: Devices that monitor heart rate, sleep, and physical activity can indirectly support brain health by encouraging healthy behaviors. For example, accelerometer-based reminders to walk every hour increased overall daily activity in adults aged 60–80, which in turn was linked to better performance on memory tests. Continuous glucose monitors are also being explored as tools to help individuals with diabetes optimize blood sugar control, which reduces long-term dementia risk.  

Virtual Reality (VR): Virtual reality (VR) interventions allow older adults to explore enriched environments that stimulate multiple senses simultaneously. Pilot studies demonstrate that VR-based navigation training can enhance hippocampal activity, which is critical for spatial memory. VR is also being tested for social engagement, enabling homebound individuals to participate in group activities or even virtual travel experiences, potentially mitigating loneliness.  

Telehealth and Cognitive Monitoring: Telehealth platforms expand access to cognitive assessments and early interventions. Remote testing of memory, attention, and language has been validated against traditional in-person evaluations, with high reliability. In addition, some health systems now provide remote coaching for lifestyle programs, helping patients sustain changes in diet, exercise, and sleep hygiene. 

Despite potential benefits, not all technology use is positive. Excessive passive screen time, particularly with social media or television, has been associated with increased depression and reduced sleep quality in older adults. Furthermore, privacy and accessibility remain concerns, especially for individuals with limited digital literacy. Experts recommend focusing on technology that actively engages cognition, supports social interaction, and reinforces healthy routines. 

Upside: When used intentionally, technology offers tools that complement traditional lifestyle strategies. From wearable monitors to virtual reality experiences, digital supports can empower older adults to remain independent, cognitively engaged, and socially connected.

Recent advances in neuroscience provide hope and clarity for older adults seeking to maintain cognitive health. Lifestyle interventions—exercise, diet, sleep, social engagement, and blood pressure control—remain the foundation of brain fitness. At the same time, early diagnostic tools, FDA-approved therapies, AI-based predictive models, and emerging neuromodulation techniques expand options for intervention. Combining these approaches enables older adults to take control of their brain health, protect cognition, and improve quality of life. Small, consistent actions implemented over time yield measurable benefits. 

Class Discussion Prompts: 

• Which of these habits feels easiest to start this week?  

• Which feels most difficult, and how could you make it simpler?    

• How could new diagnostics or therapies integrate with your current lifestyle choices? 

Alzheimer’s Association. (2023, July 6). Alzheimer’s Association welcomes U.S. FDA traditional approval of Leqembi. https://www.alz.org/ 

 
Alzheimer’s Association. (2024, July 2). Alzheimer’s Association welcomes U.S. FDA approval of Kisunla (donanemab). https://www.alz.org/ 

 
Anderson, B. A., Li, L., & Reuter-Lorenz, P. A. (2019). Neuroplasticity in older adults: Evidence from cognitive training and learning new skills. Frontiers in Aging Neuroscience, 11, 123. https://www.frontiersin.org/articles/10.3389/fnagi.2019.00123/full  

 Ashton, N. J., Pascoal, T. A., Karikari, T. K., Benedet, A. L., Lantero-Rodriguez, J., Brinkmalm, G., … Hansson, O. (2024). Plasma p-tau217 as a biomarker for Alzheimer’s disease pathology. JAMA Neurology, 81(3), 255–266. https://pubmed.ncbi.nlm.nih.gov/38252443/  

 
Barnes, L. L., Agarwal, P., & Morris, M. C. (2023). The MIND diet randomized trial: Results on cognitive outcomes. JAMA. https://jamanetwork.com/  

 Bier, N., Grenier, S., Brodeur, C., Gauthier, S., Gilbert, B., Hudon, C., & Macoir, J. (2018). Virtual reality for the assessment of everyday cognition in older adults. Frontiers in Aging Neuroscience, 10, 365. https://doi.org/10.3389/fnagi.2018.00365  

 
Biessels, G. J., & Despa, F. (2018). Cognitive decline and dementia in diabetes mellitus: Mechanisms and clinical implications. Nature Reviews Endocrinology, 14(10), 591–604. https://doi.org/10.1038/s41574-018-0048-7  

 Centers for Medicare & Medicaid Services (CMS). (2023, July 6). Statement: Broader Medicare coverage of Leqembi available following FDA traditional approval. https://www.cms.gov/ 

BrightFocus Foundation. (2025). What AI means for Alzheimer’s: 6 things an expert wants you to know. https://www.brightfocus.org/resource/what-ai-means-for-alzheimers-6-things-an-expert-wants-you-to-know  

 
Cullen, B., Martin, S., Evans, J. J., & O’Neill, B. (2021). Can telehealth support cognitive assessment and rehabilitation? A systematic review. BMC Geriatrics, 21, 35. https://doi.org/10.1186/s12877-021-02005-0  

 
Cummings, J., Lee, G., Zhong, K., Fonseca, J., & Taghva, K. (2022). Alzheimer’s disease drug development pipeline: 2022. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 8, e12345. https://doi.org/10.1002/trc2.12345  

 
Eisai Co., Ltd. (2023, January 7). FDA grants accelerated approval for LEQEMBI (lecanemab). https://www.eisai.com/  

 
Eisai Co., Ltd. (2023, July 7). FDA grants traditional approval for Leqembi. https://www.eisai.com/    

 
Food and Drug Administration (FDA). (2023, July 6). FDA converts novel Alzheimer’s disease treatment to traditional approval. https://www.fda.gov/  

 
Food and Drug Administration (FDA). (2024). FDA approves treatment for adults with Alzheimer’s disease (Kisunla, donanemab). https://www.fda.gov/  

 
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2018). An active and socially integrated lifestyle in late life might protect against dementia. The Lancet Neurology, 17(6), 520–529. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30104-4/fulltext         

 
Hansen, D. V., Hanson, J. E., & Sheng, M. (2020). Neurogenesis in the adult hippocampus. Cold Spring Harbor Perspectives in Biology, 12(9), a038994. https://cshperspectives.cshlp.org/content/12/9/a038994  

 
Hernandez, H., Reilly, C., Wadsworth, L., & McNevin, N. (2021). Activity monitors improve physical activity and cognition in older adults: A randomized controlled trial. Journal of Aging and Physical Activity, 29(2), 265–276. https://doi.org/10.1123/japa.2020-0143  

 
Kelly, M. E., Loughrey, D., Lawlor, B. A., Robertson, I. H., Walsh, C., & Brennan, S. (2014). The impact of cognitive training and mental stimulation on cognitive and everyday functioning of healthy older adults: A systematic review and meta-analysis. Ageing Research Reviews, 15, 28–43. https://doi.org/10.1016/j.arr.2014.02.004        

 
Lampit, A., Hallock, H., & Valenzuela, M. (2020). Computerized cognitive training in older adults: A systematic review and meta-analysis. PLoS Medicine, 17(3), e1003025. https://doi.org/10.1371/journal.pmed.1003025  

 
Li, L., & Lin, L. (2020). Associative memory training in older adults: Enhancing neural networks for cognition. Neuropsychology, Development, and Cognition, 27(6), 895–913. https://www.tandfonline.com/doi/full/10.1080/13825585.2020.1715470  

 
Lin, F. R., Deal, J. A., & Carlson, M. C. (2023). Hearing intervention versus health education control in the ACHIEVE randomized trial. The Lancet. https://www.thelancet.com/  

 
Lin, F. R. (2024, October 3). Hearing intervention, cognition, and brain health: Results from the ACHIEVE trial [Slides]. Canadian Academy of Audiology. https://canadianaudiology.ca/  

 
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., … Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 update of the Lancet Commission. The Lancet. https://www.thelancet.com/  

 
Marlatt, M. W., & Lucassen, P. J. (2021). Neurogenesis and memory in aging: Lifestyle interventions to enhance hippocampal plasticity. Trends in Cognitive Sciences, 25(9), 789–805. https://www.cell.com/trends/cognitive-sciences/fulltext/S1364-6613(21)00112-0  

 
Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Barnes, L. L., Bennett, D. A., & Aggarwal, N. T. (2015). MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimer’s & Dementia, 11(9), 1007–1014. https://pubmed.ncbi.nlm.nih.gov/25681666/  

 National Institute on Aging (NIA). (2023). Exercise and physical activity: Your everyday guide. https://www.nia.nih.gov/  

 
National Institute on Aging (NIA). (2024). What happens to the brain in Alzheimer’s disease? https://www.nia.nih.gov/  

 
National Institute on Aging (NIA). (2025). U.S. POINTER study results. https://www.nia.nih.gov/  

 
National Institute on Aging (NIA). (2024). AI speech analysis predicted progression of cognitive impairment to Alzheimer’s disease with over 78% accuracy. https://www.nia.nih.gov/news/ai-speech-analysis-predicted-progression-cognitive-impairment-alzheimers-over-78-accuracy  

 
National Library of Medicine (PMC). (2023). Beyond its psychiatric use: The benefits of low-dose lithium supplementation. https://pmc.ncbi.nlm.nih.gov/articles/PMC10227915/  

 
Pascual-Leone, A., Amedi, A., Fregni, F., & Merabet, L. B. (2021). The plastic human brain cortex. Annual Review of Neuroscience, 44, 167–189. https://doi.org/10.1146/annurev-neuro-080320-075004  

 
Park, D. C., & Bischof, G. N. (2019). The aging mind: Neuroplasticity in response to cognitive training. Gerontology, 65(2), 1–11. https://www.karger.com/Article/FullText/493574  

 
Raz, N., Daugherty, A. M., & Head, D. (2021). Structural brain aging: Evidence for variability and resilience. Annual Review of Psychology, 72, 271–295. https://www.annualreviews.org/doi/10.1146/annurev-psych-010419-050812  

 
SPRINT MIND Investigators. (2019). Effect of intensive versus standard blood pressure control on probable dementia: A randomized clinical trial. JAMA, 321(6), 553–561. https://jamanetwork.com/
Stern, Y. (2019). Cognitive reserve in ageing and Alzheimer’s disease. The Lancet Neurology, 18(11), 1012–1023. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30231-3/fulltext  

 
Twenge, J. M., Spitzberg, B. H., & Campbell, W. K. (2019). Less in-person social interaction with peers among U.S. adolescents and young adults in the 21st century and links to loneliness. Journal of Social and Personal Relationships, 36(6), 1892–1913. https://doi.org/10.1177/0265407519836170  

 
Violante, I. R., et al. (2023). Noninvasive temporal interference stimulation of deep brain regions in humans. Nature Neuroscience, 26, 1051–1057. https://www.nature.com/  

 
Widge, A. S., et al. (2023). Closing the loop in psychiatric deep brain stimulation. npj Digital Medicine, 6, Article 143. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC/
Xu, Y., et al. (2024). Effects of tDCS on cognition in MCI: A mixed-evidence meta-analysis. Frontiers in Aging Neuroscience. https://frontiersin.org/  

 
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., … Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. https://www.science.org/  

 
World Economic Forum. (2025, June). 8 recent breakthroughs in the fight against Alzheimer’s disease. https://www.weforum.org/stories/2025/06/recent-breakthroughs-fight-against-alzheimers-disease